acquired
Stage
3
Investors
About
Asuragen leverages RNA expertise to develop novel diagnostic products focused on personalized medicine for cancer patients, facilitating early diagnosis and treatment outcome.
Explore Asuragen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.